7Wald DS,Wald NJ.The polypill in the primary prevention of cardiovascular disease.Fundam Clin Pharmacol,2010,24:29-35.
8Vijay K,Bhagwat P,Saranjit S.Pharmaceutical issues in the development of a polypill for the treatment of cardiovascular diseases.Drug Discov Today Ther Strateg,2008,5:63-71.
9Newby LK,LaPointe NM,Chen AY,et al.Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease.Circulation,2006,113:203-212.
